• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Cell Impact reports limited liquidity following delayed transaction

CIRegulatory press release2026-06-17 11:45
Download the release

Cell Impact has in recent years described the market as cautious, characterised by delays. Today, Cell Impact reports a further delay.

Sales of machinery has in recent times been a complementary area of focus. The current delay relates to a substantial transaction concerning the sale of a large number of machines.

"Our unique forming technology formed the basis of this agreement, and we had strong and realistic expectations of completing the transaction in June. Unfortunately, delays arose in the customer's project, which materialised at a very late stage of the negotiations," says Daniel Vallin, CEO of Cell Impact.

As a result of this latest delay, Cell Impact's available cash is expected to be sufficient only until the end of June. The company and its board are currently working to identify a solution to the situation.

This information is inside information that Cell Impact AB is obliged to make public pursuant to the EU Market Abuse Regulation.